Apollomics (APLM) Non-Current Assets (2021 - 2025)

Apollomics (APLM) posted quarterly Non-Current Assets of $663000.0 for Q4 2025, down 76.58% year-on-year from $2.8 million in Q4 2024, and down 33.03% on a QoQ basis from $990000.0 in Q2 2025.

Apollomics (APLM) Non-Current Assets (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Non-Current Assets for 5 consecutive years, with $663000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Non-Current Assets fell 76.58% year-over-year to $663000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $663000.0 (down 76.58% YoY) and the FY2025 annual result came in at $663000.0, down 76.58% from the prior year.
  • Non-Current Assets slipped to $663000.0 in Q4 2025 per APLM's latest filing, from $990000.0 in the prior quarter.
  • Over the last five years, Non-Current Assets for APLM reached as high as $20.7 million in Q4 2022 and fell as low as -$99.4 million in Q4 2021.
  • A 5-year average of -$4.6 million and a median of $4.5 million in 2024 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets jumped 120.82% — and 2025, when it tumbled 83.93%.
  • Year by year, Non-Current Assets stood at -$99.4 million in 2021, then soared by 120.82% to $20.7 million in 2022, then dropped by 25.25% to $15.5 million in 2023, then sank by 81.69% to $2.8 million in 2024, then slumped by 76.58% to $663000.0 in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $663000.0, $990000.0, and $2.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Apollomics 2.66 Bn 2.66 Bn - 663,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 663,000.00
Jun 30, 2025 990,000.00
Dec 31, 2024 2.83 Mn
Jun 30, 2024 6.16 Mn
Dec 31, 2023 15.46 Mn
Jun 30, 2023 16.00 Mn
Dec 31, 2022 20.69 Mn
Dec 31, 2021 -99.37 Mn